EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Toxicity outcomes of concurrent radiotherapy with adjuvant capecitabine in triple-negative breast cancer (TROD 06-24)

Volkan Demircan, Berrin Benli Yavuz, Bekir Hakan Bakkal, Sukran Celikarslan, Sule Karabulut Gul, Huseyin Tepetam, Didem Colpan Oksuz, Alaettin Arslan, Ayse Altinok

Discover Oncology · 21.06.2026 · 17 (1)

DOI: 10.1007/s12672-026-05481-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Discover Oncology, online erschienen am 21.06.2026. Verfasst von Volkan Demircan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Radiation Oncology Department, Faculty of Medicine, Goztepe Memorial Hospital, Bahcesehir University, Altunizade Mah. Sehit Erol Olcok Sok. No:7 Alba…. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

CapecitabineRadiotherapySide effectsToxicityTriple negative breast cancer

Autor:innen und Institutionen

  • Radiation Oncology Department, Faculty of Medicine, Goztepe Memorial Hospital, Bahcesehir University, Altunizade Mah. Sehit Erol Olcok Sok. No:7 Albayrak Sitesi B blok daire:18, Uskudar, Istanbul, Turkey. nvdemircan@gma…
  • Radiation Oncology Department, Necmettin Erbakan University Faculty of Medicine, Konya, Turkey.
  • Radiation Oncology Department, Bulent Ecevit University Faculty of Medicine, Zonguldak, Turkey.
  • Radiation Oncology Department, Koc University Faculty of Medicine, Istanbul, Turkey.
  • Radiation Oncology Department, Dr. Lutfi Kirdar Kartal City Hospital, Health Science University, Istanbul, Turkey.
  • Cerrahpasa Medical Faculty Radiation Oncology Department, Istanbul, Turkey.

Zitieren

APA

Demircan, V., Benli Yavuz, B., Bakkal, B. H., Celikarslan, S., Karabulut Gul, S., Tepetam, H., Colpan Oksuz, D., Arslan, A., & Altinok, A. (2026). Toxicity outcomes of concurrent radiotherapy with adjuvant capecitabine in triple-negative breast cancer (TROD 06-24). Discover Oncology, 17(1). https://doi.org/10.1007/s12672-026-05481-4

Vancouver

Demircan V, Benli Yavuz B, Bakkal BH, Celikarslan S, Karabulut Gul S, Tepetam H, et al. Toxicity outcomes of concurrent radiotherapy with adjuvant capecitabine in triple-negative breast cancer (TROD 06-24). Discover Oncology. 2026;17(1). doi:10.1007/s12672-026-05481-4

BibTeX
@article{Demircan2026,
  author = {Demircan, Volkan and Benli Yavuz, Berrin and Bakkal, Bekir Hakan and Celikarslan, Sukran and Karabulut Gul, Sule and Tepetam, Huseyin and Colpan Oksuz, Didem and Arslan, Alaettin and Altinok, Ayse},
  title = {Toxicity outcomes of concurrent radiotherapy with adjuvant capecitabine in triple-negative breast cancer (TROD 06-24)},
  journal = {Discover Oncology},
  year = {2026},
  volume = {17},
  number = {1},
  doi = {10.1007/s12672-026-05481-4}
}
Kostenlos starten →